AKOYA BIOSCIENCES INC (AKYA)

US00974H1041 - Common Stock

3.96  +0.14 (+3.66%)

After market: 3.96 0 (0%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to AKYA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 9.01. This target is 127.52% above the current price.
AKYA was analyzed by 15 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about AKYA.
In the previous month the buy percentage consensus was at a similar level.
AKYA was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 3.967.078.679.0111.55 - 78.54% 118.94% 127.52% 191.67%
Up and Down Grades
Date Firm Action Rating
2024-03-06 JP Morgan Maintains Overweight -> Overweight
2024-03-05 UBS Maintains Buy -> Buy
2024-03-05 Canaccord Genuity Reiterate Buy -> Buy
2023-12-14 Guggenheim Initiate Neutral
2023-11-13 Stephens & Co. Maintains Overweight -> Overweight
2023-11-13 Piper Sandler Maintains Overweight -> Overweight
2023-10-24 Morgan Stanley Maintains Overweight -> Overweight
2023-10-16 Piper Sandler Maintains Overweight -> Overweight
2023-10-12 UBS Maintains Buy -> Buy
2023-08-08 Stephens & Co. Reiterate Overweight -> Overweight
2023-08-08 Morgan Stanley Maintains Overweight -> Overweight
2023-05-10 Morgan Stanley Maintains Overweight
2023-03-21 Stephens & Co. Reiterate Overweight
2023-03-08 Morgan Stanley Maintains Overweight
2022-11-03 Capital One Initiate Overweight
2022-10-06 Stephens & Co. Initiate Overweight
2022-08-17 Piper Sandler Maintains Overweight
2022-06-22 BTIG Initiate Buy
2022-05-16 Piper Sandler Maintains Overweight
2022-05-09 Morgan Stanley Maintains Overweight
2022-02-15 Morgan Stanley Maintains Overweight
2021-05-11 JP Morgan Initiate Overweight
2021-05-11 Canaccord Genuity Initiate Buy
2021-05-11 Morgan Stanley Initiate Overweight
2021-05-11 Piper Sandler Initiate Overweight